The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Open accessAbstract
Hypertension is common among patients with diabetes, with the prevalence depending on type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and the presence of kidney disease, among other factors (1-3).Furthermore, hypertension is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications.ASCVDddefined as acute coronary syndrome, myocardial infarction (MI), angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origindis the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes.Numerous studies have shown that antihypertensive therapy reduces ASCVD events, heart failure, and microvascular complications in people with diabetes (4-8).Large benefits are seen when multiple risk factors are addressed simultaneously (9).There is evidence that ASCVD morbidity and mortality have decreased for people with diabetes since 1990 (10,11) likely due in large part to improvements in blood pressure control (12-14).This Position Statement is intended to update the assessment and treatment of hypertension among people with diabetes, including advances in care since the American Diabetes Association (ADA) last published a Position Statement on this topic in 2003 (3). DEFINITIONS, SCREENING, AND DIAGNOSISRecommendations c Blood pressure should be measured at every routine clinical care visit.Patients found to have an elevated blood pressure ($140/90 mmHg) should have blood pressure confirmed using multiple readings, including measurements on a separate day, to diagnose hypertension.B c All hypertensive patients with diabetes should have home blood pressure monitored to identify white-coat hypertension.B c Orthostatic measurement of blood pressure should be performed during initial evaluation of hypertension and periodically at follow-up, or when symptoms of orthostatic hypotension are present, and regularly if orthostatic hypotension has been diagnosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (70,71), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (72,73), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antihypertensive therapy reduces the risk of albuminuria (67)(68)(69)(70), and among people with type 1 or 2 diabetes with established CKD (eGFR <60 mL/min/1.73m 2 and UACR $300 mg/g creatinine), ACE inhibitor or ARB therapy reduces the risk of progression to ESKD (71)(72)(73)(74)(75)(76)(77)(78)(79)(80).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“For individuals with albuminuria (urine albumin-to-creatinine ratio [UACR] $30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (21) (Fig. 10.2).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [21]
In the citing paper
“For patients with albuminuria (urine albumin-to-creatinine ratio [UACR] $ 30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (20) ( Fig. 10.2 ).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Flagged first, then by citations
Research works printed but not linked: 1
- Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet], 2014. Rockville, MD, Agency for Healthcare Research and Quality (US), 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK241537/. Accessed 11 November 2016
Cited by
Sorted by citations
Items 201–300 of 714
Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
Brown, R. B. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666191104113236 · Cited by 16
de Oliveira, A. A., Faustino, J., Webb, R. C., & Nunes, K. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-68919-x · Cited by 17
de Farias, C. B., Zelmanovitz, T., Coelli, S., Satler, F., Duarte, C. K., Brondani, L. D. A., & Silveiro, S. P. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.10.002 · Cited by 17
Beasley, J. M., Shah, M. K., Wyatt, L. C., Zanowiak, J. M., Trinh‐Shevrin, C., & Islam, N. S. (2021) · American Journal of Public Health · doi:10.2105/ajph.2021.306216 · Cited by 17
Ferreira, R. D. C., Cecatto, R. B., Perez, S. T., Mesquita‐Ferrari, R. A., Bussadori, S. K., Duran, C. C. G., Horliana, A. C. R. T., & Fernandes, K. P. S. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202300412 · Cited by 16
Yen, F., Wei, J. C., Shih, Y., Hsu, C., & Hwu, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.756189 · Cited by 16
Sakboonyarat, B., Poovieng, J., Srisawat, P., Hatthachote, P., Mungthin, M., Rangsin, R., & Jongcherdchootrakul, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-34023-z · Cited by 16
Wang, Y., Yu, H., Wang, L., Hu, J., & Feng, J. (2023) · Biomaterials Science · doi:10.1039/d3bm00463e · Cited by 16
Hung, W., Sutopo, C. C. Y., Mahatmanto, T., Wu, M., & Hsu, J. (2024) · Biomedicines · doi:10.3390/biomedicines12112452 · Cited by 16
Optimal blood pressure target and measurement in patients with chronic kidney disease
Kim, C., Choi, H.-S., Bae, E., Kim, S., & Ma, S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.164 · Cited by 14
Dedefo, M. G., Gemechu, D. B., Fekadu, G., & Dibessa, T. T. (2020) · International Journal of Hypertension · doi:10.1155/2020/7526257 · Cited by 16
Kotiso, K. S., Degemu, N., Gebremedhin, S., Taye, M., Petros, A., Belayneh, F., Wolde, D., & Hailu, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256399 · Cited by 17
Cardiovascular risk management in type 1 diabetes
Teoh, I. H., Elisaus, P., & Schofield, J. D. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01400-9 · Cited by 15
The Relationship Between Racial/Ethnic Concordance and Hypertension Control
Adriano, F., Burchette, R. J., Ma, A. C., Sanchez, A., & Ma, M. (2021) · The Permanente Journal · doi:10.7812/tpp/20.304 · Cited by 15
Cacciapaglia, F., Spinelli, F. R., Bartoloni, E., Bugatti, S., Erre, G. L., Fornaro, M., Manfredi, A., Piga, M., Sakellariou, G., Viapiana, O., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062148 · Cited by 15
Bruder‐Nascimento, A., Awata, W. M. C., Alves, J. V., Singh, S., da Costa, R. M., & Bruder-Nascimento, T. B. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030353 · Cited by 15
Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R. K., TIWASKAR, M. H., Chatterjee, N., Chakrabarty, S., Singh, D. P., Murthy, L. S., et al. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0620 · Cited by 16
Lee, H., Park, M.-B., & Won, Y. (2025) · JMIR Formative Research · doi:10.2196/57874 · Cited by 15
Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes
Pilla, S. J., Yeh, H. C., MITCHELL, C. M., Miller, E. R., Oh, S., White, K. N., Durkin, N., Stein, A. A., Charleston, J. B., Lu, M., et al. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.1580 · Cited by 19
Recent advances in understanding the circadian clock in renal physiology
Crislip, G. R., Masten, S., & Gumz, M. L. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.06.002 · Cited by 15
Wilson, J. R., Kerman, S. R. J., Hubers, S. A., Yu, C., Nian, H., Grouzmann, E., Eugster, P. J., Mayfield, D., & Brown, N. J. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00185 · Cited by 15
Ahn, S., Lee, J., Ji, S. M., Kim, K. H., Park, J. H., & Hyun, M. K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18042085 · Cited by 16
Hossain, M. B., Khan, J. R., & Gupta, R. D. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050493 · Cited by 15
Sreedevi, A., Vijayakumar, K., Menon, V. B., Mathew, M. M., Nair, R. R., Pillai, G. S., Numpelil, M., Menon, J. C., & Marwaha, V. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.778235 · Cited by 16
Nuyujukian, D. S., Zhou, J. J., Koska, J., & Reaven, P. D. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002931 · Cited by 14
Glycemic Targets and Prevention of Complications
Tsushima, Y., & Galloway, N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae776 · Cited by 15
Alimbayev, A., Zhakhina, G., Gusmanov, A., Sakko, Y., Yerdessov, S., Arupzhanov, I., Kashkynbayev, A., Zollanvari, A., & Gaipov, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-35551-4 · Cited by 14
Treatment strategies for hypertension in patients with type 1 diabetes
Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1729124 · Cited by 15
Chen, Y.-S., Weng, S., Chang, S.-H., Li, R., Shane, G., Hsu, J.-P., Yeh, S.-W., Chang, A.-C., & Lee, M.-J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255405 · Cited by 14
Long-Term Hypertension Risk Prediction with ML Techniques in ELSA Database
Dritsas, E., Fazakis, N., Kocsis, O., Fakotakis, N., & Μουστάκας, Κ. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-92121-7_9 · Cited by 14
Gupta, H. R., Vidhale, T., Pustake, M., Gandhi, C., & Roy, T. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2061415 · Cited by 10
Shin, D., Bohra, C., & Kongpakpaisarn, K. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11422 · Cited by 14
Xu, J., Zhao, J., Gu, J., Wang, W., & Chen, J. (2025) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2025.2496514 · Cited by 14
Salinero-Fort, M. Á., Mostaza-Prieto, J. M., Lahoz, C., Díez, J. I. V., & Cárdenas‐Valladolid, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030344 · Cited by 13
Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?
Saeed, Z. I., Ostrominski, J. W., & Aroda, V. R. (2024) · Diabetes Care · doi:10.2337/dci24-0035 · Cited by 15
Blood pressure targets for hypertension in patients with type 2 diabetes
Aronow, W. S., & Shamliyan, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.36 · Cited by 15
Jeon, S., Shin, J.-Y., Yee, J., Park, T., & Park, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217189 · Cited by 13
Raghavan, S., Ho, Y.-L. A., Kini, V., Rhee, M. K., Vassy, J. L., GAGNON, D. R., Cho, K., Wilson, P. W. F., & Phillips, L. S. (2019) · Diabetes Care · doi:10.2337/dc19-0686 · Cited by 13
Diabetes and CVD Risk: Special Considerations in African Americans Related to Care
Wittwer, J. A., Golden, S. H., & Joseph, J. J. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00648-2 · Cited by 13
Jiang, L., Ren, Y., Yu, H., Guo, Y., Liu, X., Deng, M., Xie, L., Gao, Y., Shen, M., Han, P., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002643 · Cited by 13
Willame, H., Wacquier, B., Point, C., Dosogne, M., Faker, M. A., Loas, G., & Hein, M. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14411 · Cited by 13
Chan, Y., Schooling, C. M., Zhao, J. V., Yeung, S. L. A., Hai, J. J., Thomas, G. N., Cheng, K. K., Jiang, C., Wong, Y., Au, K., et al. (2022) · Genes & Nutrition · doi:10.1186/s12263-022-00704-z · Cited by 13
Fundoiano-Hershcovitz, ., Bacher, D., Ritholz, M. D., Horwitz, D. L., Manejwala, O., & Goldstein, P. (2022) · Journal of Medical Internet Research · doi:10.2196/32923 · Cited by 14
Chen, K., Wu, Z., Shi, R., Wang, Q., Yuan, X., Wu, G., Shi, G., Li, C., & Chen, T. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110600 · Cited by 14
The ABCs of chronic kidney disease
Zuber, K., & Davis, J. S. (2018) · JAAPA · doi:10.1097/01.jaa.0000545065.71225.f5 · Cited by 13
Miller, R. G., & Costacou, T. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1240-4 · Cited by 14
Han, S. Y., & Choi, Y. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050468 · Cited by 13
Clinical and biochemical correlates of hypogonadism in men with type 2 diabetes mellitus
Musa, E., El-Bashir, J. M., Bello-Sani, F., & Bakari, A. G. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.292.25719 · Cited by 13
Akpalu, J., Yawson, A. E., Osei‐Poku, F., Atiase, Y., Yorke, E., Adjei, P., Nkromah, K., & Akpalu, A. K. (2018) · Stroke Research and Treatment · doi:10.1155/2018/7521351 · Cited by 15
Physician Preferences for an Electronic Lung Cancer Screening Decision Aid
Morgan, O. (2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89551 · Cited by 14
Variation in Patient Smoking Cessation Rates Among Health-Care Providers
Almaaitah, S., Ciemins, E. L., Joshi, V., Arora, A., Meskow, C., & Rothberg, M. B. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.599 · Cited by 12
Hu, X., Wu, H.-F., Li, Y., Wang, Y., Cheng, H., Wang, J., Mohammed, B. H., Tan, I., & Wang, H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108539 · Cited by 13
Naghipour, M., Joukar, F., Salari, A., Asgharnezhad, M., Hassanipour, S., & Mansour‐Ghanaei, F. (2021) · Annals of Global Health · doi:10.5334/aogh.3027 · Cited by 12
Sapra, A., Bhandari, P., & Wilhite, A. (2021) · Cited by 12
Valenzuela, P. L., Santos‐Lozano, A., Castillo‐García, A., Ruilope, L. M., & Lucía, A. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2022.01.014 · Cited by 12
Kundu, S., Rahman, M. A., Kabir, H., Banna, M. H. A., Hagan, J. E., Srem‐Sai, M., & Wang, L. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10010007 · Cited by 12
Determinants of hypertension among diabetic patients in southern Ethiopia: a case-control study
Anjajo, E. A., Workie, S. B., Tema, Z. G., Woldegeorgis, B. Z., & Bogino, E. A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03245-4 · Cited by 17
Risk factors for decline in renal function among young adults with type 1 diabetes
Schwandt, A., Bergis, D., Denkinger, M. D., Gollisch, K. S. C., Sandig, D., Stingl, H., Zimny, S., & Holl, R. W. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.07.007 · Cited by 12
Patoulias, D., Stavropoulos, K., Imprialos, K. P., Athyros, V. G., Doumas, M. N., & Karagiannis, A. I. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190426162746 · Cited by 13
Shahraki, R. A., kamrani, A. A., Sahaf, R., & Momtaz, Y. A. (2019) · Salmand · doi:10.32598/sija.14.1.84 · Cited by 12
Yen, F., Wei, J. C., Lin, M., Hsu, C., & Hwu, C. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00690-0 · Cited by 15
Pan, Q., Hui, D., & Hu, C. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1914081 · Cited by 12
García, P. P., Martínez, F. J. H., López, N. A., Torre, L. J. C., & Sempere, M. E. T. (2022) · Antioxidants · doi:10.3390/antiox11010116 · Cited by 14
Bhattacharya, S., Kalra, S., Kapoor, N., Singla, R., Dutta, D., Aggarwal, S., Khandelwal, D., Surana, V., Dhingra, A., Kantroo, V., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1587 · Cited by 12
Oyeleye, S. I., Ademiluyi, A. O., Ojo, O. R., & Oboh, G. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14475 · Cited by 11
Barsasella, D., Bah, K., Mishra, P., Uddin, M., Dhar, E., Suryani, D. L., Setiadi, D. R., Masturoh, I., Sugiarti, I., Jonnagaddala, J., et al. (2022) · Medicina · doi:10.3390/medicina58111568 · Cited by 11
Ismail, R., Ismail, N. H., Tamil, A. M., Jaáfar, M. H., Isa, Z. M., Nasir, N. M., Ariffin, F., Ramli, A. S., Abidin, N. Z., Razak, N. H. A., et al. (2023) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2023.101279 · Cited by 11
Supervised Machine Learning-Based Models for Predicting Raised Blood Sugar
Owess, M. M., Owda, A. Y., Owda, M., & Massad, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21070840 · Cited by 17
Illuminating Racial Inequity in Diabetes Control: Differences Based on Gender and Geography
Senteio, C. R., & Akıncıgil, A. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00830-7 · Cited by 14
Lee, M. H.-Y., Leda, M., Buchan, T. A., Malik, A., Rigobon, A. V., Liu, H., Daza, J. F., O’Brien, K., Stein, M., Hing, N. N. F., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10086-w · Cited by 11
Association of Pulse Pressure Difference and Diabetes Mellitus in Chinese People: A Cohort Study
Wu, C., Ma, D., & Chen, Y. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s327841 · Cited by 11
Rahman, M. A., Halder, H. R., Kundu, S., Sultana, F., & Islam, S. M. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109873 · Cited by 12
Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
Lamprea-Montealegre, J. A., & de Boer, I. H. (2018) · Diabetes Care · doi:10.2337/dci17-0063 · Cited by 11
Montvida, O., Cai, X., & Paul, S. K. (2019) · Diabetes Care · doi:10.2337/dc18-1865 · Cited by 10
Bayesian Double Feature Allocation for Phenotyping With Electronic Health Records
Ni, Y., Müller, P., & Ji, Y. (2019) · Journal of the American Statistical Association · doi:10.1080/01621459.2019.1686985 · Cited by 11
Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach
Alencherry, B., & Laffin, L. J. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01443-0 · Cited by 11
Chiu, C., Li, M.-L., Chang, C., Wu, C., & Tan, M. P. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02300-z · Cited by 14
Knockout of Macula Densa Neuronal Nitric Oxide Synthase Increases Blood Pressure in db/db Mice
Zhang, J., Wang, X., Cui, Y., Jiang, S., Wei, J., Chan, J., Thalakola, A., Le, T., Xu, L., Zhao, L., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17643 · Cited by 11
Koh, J.-A., Ong, J., Manan, F. A., Ee, K. Y., Wong, F., & Chai, T. (2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac124.49294944 · Cited by 11
Alicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00003-3 · Cited by 11
James, S., Perry, L., LOWE, J. M., Harris, M., Colman, P. G., Craig, M. E., Australasian Diabetes Data Network Study Group, Anderson, K. P., Andrikopoulos, S., Ambler, G. R., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02057-4 · Cited by 12
Ahmed, A., Amin, H., Drenos, F., Sattar, N., & Yaghootkar, H. (2023) · Diabetes Care · doi:10.2337/dc23-0855 · Cited by 10
Blood Pressure Control and Cardiovascular/Renal Outcomes
Dojki, F. K., & Bakris, G. L. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.008 · Cited by 11
Self-citationRoopashree, S., Prathab, A. G., & Sandeep, T. (2021) · Indian Journal of Microbiology Research · doi:10.18231/j.ijmr.2021.016 · Cited by 10
Santra, A., & Mallick, A. (2022) · Annals of Human Biology · doi:10.1080/03014460.2022.2072525 · Cited by 10
Li, S., Yang, B., Shang, S., & Jiang, W. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15986 · Cited by 10
Xu, R. H., Wong, E. L., & Cheung, A. W.-L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039397 · Cited by 10
Marahrens, B., Schulze, A., Wysocki, J. A., Lin, M., Ye, M., Kanwar, Y. S., Bäder, M., Velez, J. C. Q., Miner, J. H., & BATLLE, D. C. (2020) · Kidney International · doi:10.1016/j.kint.2020.11.012 · Cited by 10
Arrieta, F., Iglesias, P., Pedro‐Botet, J., Becerra, A., Ortega, E., Obaya, J. C., Nubiola, A., Maldonado, G. F., Campos, M. D. M., Petrecca, R., et al. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.05.002 · Cited by 10
Akalu, Y., Yeshaw, Y., Tesema, G. A., Tiruneh, S. A., Teshale, A. B., Angaw, D. A., Worku, M. G., & Dagnew, B. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02090-4 · Cited by 10
Yang, R., Bai, J., Fang, Z., Wang, Y., Feng, Y., Liu, Y., Chi, H., Deng, Y., Song, Q., & Cai, J. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14927 · Cited by 10
Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes
Schroeder, E. B., Chonchol, M., Shetterly, S. M., Powers, J. D., Adams, J., Schmittdiel, J. A., Nichols, G. A., O’Connor, P. J., & Steiner, J. F. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09510817 · Cited by 10
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Solini, A., Penno, G., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Lamacchia, O., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1313-x · Cited by 10
Marx, N., Rydén, L., Brosius, F. C., Ceriello, A., Cheung, M., Cosentino, F., Green, J., Kellerer, M., Koob, S., Kosiborod, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108092 · Cited by 10
Olsen, E., Holzhauer, B., Julius, S., Kjeldsen, S. E., Larstorp, A. C. K., Mancia, G., Mehlum, M. H., Mo, R., Rostrup, M., Søraas, C. L., et al. (2021) · Blood Pressure · doi:10.1080/08037051.2020.1855968 · Cited by 10
Shoily, S. S., Ahsan, T., Fatema, K., & Sajib, A. A. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104888 · Cited by 10
Sharma, S. K., Thakur, K., Kant, R., & Mudgal, S. K. (2021) · Cureus · doi:10.7759/cureus.20436 · Cited by 10
Kuang, Z., Hou, N., Kan, C., Han, F., Qiu, H., & Sun, X. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03355-6 · Cited by 10
Chi, F., Parthasarathy, S., Palzes, V. A., Kline‐Simon, A. H., Weisner, C. M., Satre, D. D., Grant, R. W., Elson, J., Ross, T. B., Awsare, S. V., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-064088 · Cited by 10
Scindia, Y. M., Gholam, M. F., Waleed, A., Liu, L., Chacko, K. M., Desai, D. N., Lopez, J. P., Malik, Z. S., Schramm, W. C., Morales, A. G., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020305 · Cited by 10
Metadata
- Authors
- de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G.
- Affiliations
- University of Washington, Seattle, WA
- New York University (US)
- Université de Lorraine, Nancy, France
- University of Chicago (US)
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Copenhagen (DK)
- Monash University (AU)
- Corresponding author
- Bakris, George
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-14
- Volume
- 40
- Issue
- 9
- Pages
- 1273-1284
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2748201042
- Semantic Scholar
- 4e3c7fd3bbe3119a559b61514192347b33e3e619
- Cited by
- 714
- References
- 145
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 89 · 2023: 69 · 2022: 102 · 2021: 113 · 2020: 83 · 2019: 81 · 2018: 71 · 2017: 5
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Ironwood Pharmaceuticals, Incorporated
- Medicines Company
- Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF14OC0013659)
- Servier
- Sanofi Australia
- Abbott Vascular
- Defense Acquisition Program Administration
- Relypsa
- National Heart, Lung, and Blood Institute
- Cilag
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, heart failure, microvascular complications, antihypertensive therapy, blood pressure screening, home blood pressure monitoring, white coat hypertension, orthostatic hypotension, blood pressure control, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
